Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
48 participants
INTERVENTIONAL
2011-01-31
2011-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Habitual Protein Intake and Muscle Protein Synthesis
NCT01986842
Dietary Strategies to Promote Muscle Protein Anabolism in the Elderly
NCT00557388
A Protein Supplementation and Exercise Strategy to Promote Muscle Protein Anabolism in Frail Elderly People
NCT01110369
Protein Supplementation to Promote Muscle Protein Anabolism in Frail Elderly People
NCT01109628
Dietary Interventions for Muscle Mass
NCT01145131
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
protein (elderly)
protein
20g protein
protein and carbohydrate (elderly)
protein and carbohydrate
20g protein and 20g carbohydrate
protein and carbohydrate (young)
protein and carbohydrate
20g protein and 20g carbohydrate
protein and leucine (elderly)
protein and leucine
20g protein, 2.5g leucine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
protein
20g protein
protein and carbohydrate
20g protein and 20g carbohydrate
protein and leucine
20g protein, 2.5g leucine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 70-85 years or 18-30 years
* BMI \< 30
Exclusion Criteria
* All co morbidities interacting with mobility and muscle metabolism of the lower limbs
* Use of anticoagulants
* Patients suffering from Phenylketonuria
* Participation in any regular exercise programme
70 Years
85 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maastricht University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
A. de Lange
Role: PRINCIPAL_INVESTIGATOR
Maastricht University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universiteit Maastricht, Bewegingswetenschappen
Maastricht, Limburg, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Information about research performed by the Maastricht Muscle Metabolism group at MUMC
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MEC 10-3-080
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.